HS

Hemangi Santosh Salunke

Active Director Designated Partner DIN 07299433
DIN 07299433 First appointment Nov 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemangi Santosh Salunke

Data last updated:

Hemangi Santosh Salunke is a Designated Partner at Ankasa Pharmaceuticals Llp (since 2015). The company operates in Business Services.

DIN 07299433
Primary Designation Designated Partner
Industry Business Services
First Appointment 29 Nov 2015
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Nov 20152015Active

Board colleagues of Hemangi Santosh Salunke

NameDINCompanyDesignation
Sarika Kashinath Mandare07299471Ankasa Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ankasa Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Hemangi Santosh Salunke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemangi Santosh Salunke

Hemangi Santosh Salunke currently holds 1 directorship: Ankasa Pharmaceuticals Llp (Designated Partner, since 29 Nov 2015).

Hemangi Santosh Salunke was first appointed on 29 Nov 2015 as Designated Partner at Ankasa Pharmaceuticals Llp.

The current boards of Hemangi Santosh Salunke's companies include Sarika Kashinath Mandare (Ankasa Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available